603439.SS · 三力制药
China A-shares · RS rating 48 · As of 2026-10-14
| Price | 11.22 CNY |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 48 / 24 / 35 / 52 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 19 / 15 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -53.5% |
| Distance from 52-week high | +34.0% |
| Market cap (USD) | $764.0M |